Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Oriella Manenti"'
Autor:
Sergio Cabibbo, Giovanna Oriella Manenti, Agostino Antolino, Massimo Poidomani, Raffaele Elia, Giuseppe A. Palumbo, Francesco Di Raimondo
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss 4, Pp 393-396 (2024)
Introduction: Polycythaemia vera patients can present with arterial or venous vascular occlusive events such as thrombosis or cardiovascular disease; disease-related symptoms may significantly impact on the quality of life. The aim of this study was
Externí odkaz:
https://doaj.org/article/b99039a181ef4f259b406bfca89fb528
Autor:
Sergio Cabibbo, Pietro Bonomo, Giovanni Garozzo, Salvatore Calabrese, Oriella Manenti, Giorgio Sallemi, Francesco Bennardello, Agostino Antolino, Giorgio Assenza
Publikováno v:
Transfusion and Apheresis Science. 40:13-17
Background We analysed the relationship between baseline haemoglobin levels and the need for post-operative blood transfusion in our patients. The aim of this study was to evaluate and optimize the pre-operative autologous blood donation (PABD) progr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57692b2984c3abd852644e99e593245a
https://doi.org/10.1016/j.transci.2008.11.010
https://doi.org/10.1016/j.transci.2008.11.010
Autor:
Giovanna Oriella Manenti, Francesco Costantino, Francesco Bennardello, Salvatore Calabrese, Pietro Bonomo, Giovanni Garozzo, Carmelo Fidone, Roberto Distefano, Sergio Cabibbo, Agostino Antolino, Simone Travali, Vincenzo Licitra
Publikováno v:
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 32(3)
We tracked the results of 394 manual or automatic red blood cell exchanges done with a cell separator in 20 sickle cell patients at high risk for recurrent complications. Over an average of 6 years, none of the patients developed complications relate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dc7d56d5274402e81106b06713707aa
https://pubmed.ncbi.nlm.nih.gov/15908276
https://pubmed.ncbi.nlm.nih.gov/15908276
Autor:
Felicina Li Gioi, Giuseppe A. Palumbo, Giovanna Oriella Manenti, Francesco Di Raimondo, Marzia Pafumi, Giuseppe Milone, Rosario Giustolisi
Mitoxantrone and Epirubicin are active agents in non-Hodgkin's lymphomas (NHL). These drugs have reduced cardiotoxicity and therefore are indicated in treatment of elderly patients. Cyclophosphamide, mitoxantrone, vincristine and methylprednisone (CN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fd33376dd8196fa0c676e793e55d253
http://hdl.handle.net/20.500.11769/23571
http://hdl.handle.net/20.500.11769/23571
Autor:
Milone, Giuseppe (AUTHOR), Di Raimondo, Francesco (AUTHOR), Li Gioi, Felicina (AUTHOR), Palumbo, Giuseppe A. (AUTHOR), Manenti, Giovanna Oriella (AUTHOR), Pafumi, Marzia (AUTHOR), Giustolisi, Rosario (AUTHOR)
Publikováno v:
Leukemia & Lymphoma. Dec2002, Vol. 43 Issue 12, p2319-2324. 6p.